CDC vaccine advisers set to review Johnson & Johnson vaccine after reports of rare blood clots
Federal health officials had recommended Tuesday that states pause use of the vaccine while agencies review six U.S. cases of a rare and severe type of brain blood clot among the more than 7 million people who received the shot.
